PDMS-PNIPAAm-Gelatin surface as well as preparation method and application thereof

Through the micro-patterned surface of PDMS-PNIPAAm-Gelatin, the problems of low differentiation efficiency and cell aging in stem cell induced differentiation are solved, and an efficient and safe in vitro induction differentiation method is provided, which realizes the purification and homogenization of hiPSCs-MSCs. .

CN118930942APending Publication Date: 2024-11-12LANZHOU UNIV
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411161363.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing stem cell-induced differentiation methods have problems with low differentiation efficiency, uncontrollable induction process, inaccurate identification standards and cell aging, especially when using serum-containing culture medium, there are risks of immune response and safety.

Method used

Using PDMS-PNIPAAm-Gelatin micro-patterned surface, a temperature-sensitive micro-patterned surface was prepared by photoinitiator treatment and gelatin modification, which was used for purification and induction of differentiation of hiPSCs-MSCs, providing a clear and efficient composition in vitro induced differentiation system.

Benefits of technology

The purification efficiency and cell survival rate of hiPSCs-MSCs are improved, intermediate cells during the induction process are reduced, serum-related adverse reactions are avoided, and non-injury cell harvesting and homogenized mesenchymal-like cell acquisition are achieved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930942A_ABST
    Figure CN118930942A_ABST
Patent Text Reader

Abstract

The invention discloses a PDMS (Polydimethylsiloxane)-PNIPAAm-Gelatin micro-patterned surface as well as a preparation method and application of the PDMS-PNIPAAm-Gelatin micro-patterned surface. The method comprises the following steps: treating a PDMS (polydimethylsiloxane) micro-patterned surface in a pore plate with a photoinitiator, quickly removing the photoinitiator, dropwise adding 1mL of an NIPAAm monomer solution into the treated pore plate, illuminating for 30 minutes under the conditions that the PDMS micro-patterned surface is 7 + / -1cm away from a light source, the irradiation intensity is 365nm and the area is 6.75 mW / cm < 2 >, and controlling the temperature of the pore plate to be not higher than 20 DEG C during illumination, washing and sterilizing the illuminated pore plate to obtain a PDMS micro-patterned surface grafted with PNIPAAm in the pore plate, adding a sterile gelatin solution with the mass percent of 0.1% into the pore plate according to 250 mu L per pore, and incubating in an incubator at 37 DEG C overnight to obtain a PDMS-PNIPAAm-Gelatin surface in the pore plate. The method successfully solves the problems that the human mesenchymal stem cells are limited in source and cannot be massively amplified.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of stem cell culture, and in particular relates to a PDMS-PNIPAAm-Gelatin micro-patterned surface and a preparation method and application thereof. Background Art

[0002] Human mesenchymal stem cells (hMSCs) can be derived from many tissues such as bone marrow, umbilical cord, and fat, and have been widely used in regenerative medicine, tissue engineering, cell therapy, and other fields. However, they have problems such as limited sources, insufficient in vitro expansion capacity, and replicative aging. Human induced pluripotent stem cells (hiPSCs) can be derived from the patient's own cells and have unlimited proliferation and multidirectional differentiation potential. Human induced pluripotent stem cell-derived mesenchymal stem cells (hiPSCs-MSCs) can be obtained through in vitro induced differentiation. Unfortunately, existing induced differentiation methods often directly use serum-containing mesenchymal culture medium, which has problems such as unclear composition and low induced differentiation rate. More importantly, mesenchymal cells lack specific markers, and continuous passaging will lead to cell senescence. There is an urgent need to develop effective cell purification methods.

[0003] The hiPSC-to-MSC differentiation process is plagued by challenges such as low differentiation efficiency, uncontrollable induction processes, and inaccurate identification standards, particularly due to significant variability in the culture media used. In early differentiation experiments, hiPSCs were typically induced into mesenchymal-like cells in basal medium (aMEM or DMEM) containing 10–20% fetal bovine serum (FBS). Studies have shown that while the addition of FBS can result in the expression of MSC-related markers in the resulting mesenchymal-like cells, the overall differentiation efficiency is low, and the presence of FBS may trigger immune responses and safety concerns. There have been reports of patients developing immune responses to FBS-induced heterologous antigens and viral transmission. Therefore, the use of animal serum-free culture media for in vitro culture and expansion has become a priority in clinical applications. Currently, basal media containing FBS or knockout serum replacement (KSR) are commonly used. Even without FBS, these animal-derived media carry limitations such as the risk of microbial infection and low selective killing. Most research has focused on identifying functional compounds that can induce hiPSC differentiation into mesectoderm. Most researchers still need to further optimize the differentiation process to obtain sufficient numbers of hiPSC-MSCs that meet clinical application requirements.

[0004] The methods for inducing hiPSCs to differentiate into hiPSC-MSCs are divided into monolayer induction method and embryoid body induction method. In the monolayer induction method, hiPSCs are plated on the surface of a cell culture plate coated with Matrigel, and then hiPSC-MSCs are gradually differentiated by using a culture medium containing different functional compounds. Compared with the embryoid body induction method, the monolayer method has the advantages of high stability, simple operation, and convenience during culture, which has attracted widespread attention. However, the more classic and common method is the embryoid body induction method. According to research reports, this method is often used to differentiate hiPSCs into various types of cells. The in vitro differentiation of hiPSCs usually requires the formation of EBs, which represents the beginning of the differentiation of hiPSCs into specific lineages. It is mainly divided into two steps: (1) Embryoid body (EBs) formation, hiPSCs are formed into embryoid bodies and suspended in ultra-low adhesion plates for a period of time. (2) Adherent culture, after a few days, EBs are plated on the surface of a modified cell culture plate for adherent culture to induce differentiation. EBs are three-dimensional (3D) aggregates of hiPSCs that can differentiate into cells of all three germ layers. Many of the events involved in the in vitro lineage-specific differentiation of EBs mirror those seen in the developing embryo, justifying their use as a model system for in vivo differentiation of hiPSCs under in vitro culture conditions. Furthermore, in vitro-formed EBs generate populations of early progenitor cells that are unavailable in vivo and have been shown to efficiently differentiate into multiple lineages, such as cardiac, neural, hematopoietic, and pancreatic β cells.

[0005] The growth and function of cells are affected by the local microenvironment, and patterning can impose a microenvironment with a specific structure on cells. The microenvironment affected by patterning further affects the structure and mechanics of the cells, and also affects the polarity and function of the applied cells. The size of the micropattern limits the cell volume and cell diffusion. Its structure (i.e., the position of adjacent cells and the position and direction of ECM fibers) determines the spatial distribution of cell adhesion and non-attached cell surfaces. The biochemical composition and stiffness of the micropattern determine the factors that can participate in cell adhesion, thereby affecting the intracellular signaling pathways. These pathways then determine the formation and dynamics of the cytoskeleton network. In addition to playing a role within the cell, the cell microenvironment also affects gene expression and cell differentiation. Therefore, the nature of the microenvironment is crucial for regulating cell function. However, the traditional continuous subculture cell purification method on micropatterned surfaces is inefficient, prone to impaired proliferation potential, and has the problem of replicative aging. Summary of the Invention

[0006] In order to overcome the shortcomings and deficiencies of the prior art, the primary purpose of the present invention is to provide a PDMS-PNIPAAm-Gelatin micro-patterned surface.

[0007] Another object of the present invention is to provide a method for preparing the above-mentioned PDMS-PNIPAAm-Gelatin micro-patterned surface.

[0008] Another object of the present invention is to provide applications of the above-mentioned PDMS-PNIPAAm-Gelatin micro-patterned surface.

[0009] The present invention is achieved by providing a method for preparing a PDMS-PNIPAAm-Gelatin micropatterned surface, the method comprising the following steps:

[0010] (1) treating the PDMS micropatterned surface in the well plate with a photoinitiator and then rapidly removing the photoinitiator;

[0011] (2) NIPAAm monomer solution was added to the treated well plate at a rate of 1 mL per well. The PDMS micro-patterned surface was irradiated at a distance of 7 ± 1 cm from the light source at an intensity of 365 nm and 6.75 mW / cm 2 The well plate was irradiated with light for 30 minutes under the following conditions, during which the temperature of the well plate was controlled to be no higher than 20° C. The well plate was washed and sterilized after irradiation to obtain a PDMS micro-patterned surface grafted with PNIPAAm in the well plate;

[0012] (3) 250 μL of a 0.1% by mass sterile gelatin solution was added to each well of the plate and incubated in a 37°C incubator overnight to obtain a PDMS-PNIPAAm-Gelatin surface in the plate.

[0013] Preferably, in step (1), the preparation process of the NIPAAm monomer solution is:

[0014] Add NIPAAm to the n-hexane solution, heat under reflux condensation and 55°C water bath. After NIPAAm is completely dissolved in n-hexane, filter while hot and collect the filtrate.

[0015] The filtrate was allowed to stand at room temperature until a large amount of crystals precipitated, and then placed in a 4°C refrigerator for 5 h. The filtrate was filtered under reduced pressure using a sand core funnel. The collected product was dried under vacuum at room temperature for 12 h to obtain recrystallized NIPAAm.

[0016] The recrystallized NIPAAm was fully dissolved in water, and sodium periodate and benzyl alcohol at a concentration of 50 mM were added to prepare a NIPAAm monomer solution with a NIPAAm concentration of 10% (w / v), a sodium periodate concentration of 0.5 mM, and a benzyl alcohol concentration of 0.5%.

[0017] Preferably, in step (2), the preparation process of the PDMS micro-patterned surface in the orifice plate is specifically as follows:

[0018] The PDMS precursor and cross-linker were thoroughly mixed at a mass ratio of 10:1, with a thickness of 0.2 mm. After degassing, the mixture was poured into a 5-40 μm chip positive mold. After the mixture was evenly spread, the mold was placed in a drying oven at 60 ± 1 ° C overnight.

[0019] After polymerization and curing, the PDMS was peeled off from the mold and cut into discs with a diameter of 14 ± 0.1 mm;

[0020] A mixture of PDMS precursor and cross-linking agent was pre-dropped into the well plate, and a disc was placed into each well of the well plate. The disc was cured at 60°C overnight and soaked in alcohol overnight to obtain a PDMS micro-patterned surface with a thickness of 5 to 40 μm.

[0021] Preferably, the mixture is degassed and poured into a 20 μm chip positive mold, and finally a PDMS micro-patterned surface with a thickness of 20 μm is obtained.

[0022] Preferably, in step (2), the PDMS micro-patterned surface in the well plate is treated with a photoinitiator by adding 1 mL of a 20% by mass benzophenone acetone solution into each well of the well plate for 5 minutes.

[0023] Preferably, in step (2), the specific process of rapidly removing the benzophenone-acetone solution is: rapidly absorbing the benzophenone-acetone solution and rinsing with a large amount of ddH2O to ensure that there is no white benzophenone precipitate on the surface.

[0024] Preferably, in step (2), the temperature of the orifice plate is controlled to be no higher than 20° C. by an ice-water bath.

[0025] Preferably, in step (2), the specific process of washing and sterilizing is: the PDMS micropatterned surface grafted with PNIPAAm in the well plate is alternately rinsed with ddH2O and acetone to remove residual monomer solution and benzophenone, and then soaked in water for 24 hours and sterilized under UV overnight.

[0026] The invention further discloses a PDMS-PNIPAAm-Gelatin surface prepared by the method.

[0027] The present invention further discloses the application of the PDMS-PNIPAAm-Gelatin surface in the mesenchymal differentiation of mesenchymal-like cells hiPSCs-MSCs derived from human induced pluripotent stem cells.

[0028] To address the problems of unclear composition and low differentiation induction rate caused by traditional continuous passage and the use of serum-containing mesenchymal induction medium, the present invention provides a PDMS-PNIPAAm-Gelatin micropatterned surface and its preparation method and application. The present invention designs a PDMS-PNIPAAm-Gelatin micropatterned surface and uses it to purify hiPSCs-MSCs obtained by embryoid body induction. The thermosensitive surface can harvest cells without damage, and the micropatterning provides an optimal purification width, allowing the screening and acquisition of a large number of homogeneous mesenchymal-like cells.

[0029] Compared with the shortcomings and deficiencies of the prior art, the present invention has the following beneficial effects:

[0030] 1. Establishing a well-defined in vitro differentiation system: Current studies for deriving hiPSC-MSCs often use culture media containing FBS, which carries the risk of microbial infection and immunogenicity. To avoid the adverse complications associated with FBS, this invention establishes a well-defined, highly efficient in vitro culture system based on the use of commercially available well-defined culture media.

[0031] 2. Exploring the differentiation efficiency of different functional compounds and establishing an in vitro differentiation induction system: This study proposes using an embryoid body (EB) method for induction. Different functional compounds will be added during the EB suspension stage, or used in combination, to investigate their effects on differentiation efficiency. Specifically, this study aims to induce hiPSCs into mesenchymal-like cells and reduce the number of intermediate cells that appear during the induction process. Furthermore, the effects of these compounds on cell survival and proliferation should not be ignored, and further research is needed to identify functional compounds that are more suitable for inducing mesenchymal differentiation.

[0032] 3. Purification of hiPSCs-MSCs on thermosensitive coating micropatterned surfaces

[0033] To address the low efficiency of traditional continuous culture cell purification methods on micropatterned surfaces, which are prone to impaired proliferation potential and replicative aging, the PDMS temperature-sensitive micropatterned surface can harvest cells without damage and provide an optimal purification width for screening large numbers of homogeneous mesenchymal-like cells, thereby improving the purification efficiency of hiPSC-MSCs.

[0034] 4. Solve the problem of limited sources of human mesenchymal stem cells and their inability to expand in large quantities

[0035] hMSCs lose their pluripotency and immunomodulatory properties after prolonged culture, and their proliferation potential is impaired, leading to replicative senescence and the inability to meet clinical demand. hiPSCs can be expanded indefinitely in vitro, making it possible to obtain large quantities of homogenized hiPSC-MSCs through in vitro differentiation. Furthermore, the proliferation rate and self-renewal capacity of hiPSC-MSCs are similar to those of adult hMSCs, and they offer advantages such as a wide range of sources, enhanced expansion capacity, low immunogenicity, and no ethical issues. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 It is a technical roadmap for the differentiation of hiPSCs into mesenchymal-like cells;

[0037] Figure 2 The figure shows the timeline of the induction of hiPSCs (hNF-C1)-derived EBs into mesoderm and mesenchyme, and the morphology of embryoid bodies in E6 medium induced by the addition of different functional compounds (TGF-β, RA) (black line scale in the figure: 100 μm);

[0038] Figure 3 are SEM images of the PDMS micropatterned surface (from left to right, widths are 0 μm, 5 μm, 10 μm, 20 μm, and 40 μm, respectively);

[0039] Figure 4 Figure 1 is the XPS analysis of the PDMS surface before and after grafting of the PNIPAAm coating; Figure a is the full spectrum of the PDMS surface; Figure b is the full spectrum of the PDMS-PNIPAAm surface; Figure c is the change in C1s element content on the PDMS-PNIPAAm surface;

[0040] Figure 5 Yes. Surface morphologies of PDMS-grafted surfaces (PDMS, PDMS-PNIPAAm, PDMS-PNIPAAm-Gelatin) with different widths (0 μm, 5 μm, 10 μm, 20 μm, 40 μm) were scanned using an atomic force microscope.

[0041] Figure 6 The roughness characterization results of different surfaces; Figure a is the calculated profile arithmetic mean deviation Ra, and Figure b is the ten-point average height Rz of the micro-roughness;

[0042] Figure 7 hiPSCs-MSCs were seeded onto PDMS-PNIPAAm-Gelatin surfaces of different widths (5μm, 10μm, 20μm, 40μm) and purified and photographed under a microscope to observe changes in cell morphology;

[0043] Figure 8hiPSCs-MSCs purified on PDMS-PNIPAAm-Gelatin surfaces with different widths (0 μm, 5 μm, 10 μm, 20 μm, 40 μm) for 5 days and adult umbilical cord-derived mesenchymal stem cells (hUMSCs) were detected by RT-PCR and flow cytometry for mesenchymal-like cell markers;

[0044] Figure 9 Figure 1 is the identification of purified hiPSCs-MSCs; Figure a shows cell proliferation, Figure b shows osteogenic and adipogenic differentiation, and Figure c shows osteogenic and chondrogenic differentiation). DETAILED DESCRIPTION

[0045] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.

[0046] 1. Using embryoid bodies to differentiate hiPSC-derived mesoderm cells into mesenchymal-like cells under defined conditions

[0047] 1. Culture of hiPSCs

[0048] The hiPSC (hNF-C1) cell line was obtained by lentiviral reprogramming of human skin fibroblasts and seeded onto the surface of a cell culture plate coated with Matrigel (1:230 dilution, prepared on ice). The culture medium of human pluripotent stem cells was changed daily. After 3-4 days, when the cells grew to 70-80% confluence, they were digested with 0.5 mM EDTA in an incubator for 4-5 minutes and then passaged at a ratio of 1:6.

[0049] 2. Formation of embryoid bodies

[0050] When the confluence of hNF-C1 cultured on the Matrigel surface reached 80% to 90%, the cells were digested with 1 mg / mL Dispase (diluted in DMEM / F12) for 15 to 20 minutes and then washed three times with DMEM / F12. The cells were then evenly scraped with a Pasteur pipette to form uniform cell clusters, which were then transferred to ultra-low adhesion plates for culture. 5 μmol / L Y-27632 was added to promote embryoid body survival.

[0051] 3. Use functional compounds to induce embryoid bodies to differentiate into mesoderm cells

[0052] After EBs were formed, they were transferred to ultra-low adhesion cell culture plates and cultured in suspension for 5 days. Serum-containing E6 medium was used as a control. E6 medium with defined components and E6 medium supplemented with 10 ng / mL TGF-β1 were selected as experimental groups. On the first day, 5 μmol / L Y-27632 was added to both the control and experimental groups. After three days of suspension culture, the experimental groups were induced to differentiate into mesoderm with or without the addition of 40 ng / mL RA for another two days.

[0053] Figure 1 The technical roadmap for the differentiation of hiPSCs into mesenchymal-like cells is shown below, in which different culture media and culture plates are used at different time periods. Figure 2 The figure shows the timeline of induction of hiPSCs (hNF-C1)-derived EBs into mesoderm and mesenchyme and the morphology of embryoid bodies in E6 culture medium induced by adding different functional compounds (TGF-β, RA). Figure 2 As shown, hNF-C1 cells began to form EBs only after reaching approximately 80% confluency. However, after suspension, EB formation was incomplete or fragmented in the control group due to the excessive toxicity of FBS. However, numerous EBs of uniform size were observed in the E6 and E6 + TGF-β groups, confirming that chemically defined groups significantly promoted the survival of hiPSC EBs. After 3 days of culture, RA treatment led to a decrease in cell survival. Furthermore, EBs exhibited a variety of morphologies, including cystic, shallow-luminal, and deep-luminal, each indicating a different differentiation tendency. Cystic EBs were primarily composed of endoderm cells, while the latter two types contained cells from all three germ layers. Furthermore, due to the cytotoxicity of RA, some EBs showed signs of cell death accompanied by peripheral fragmentation. Similarly, on the final day, 5, EB survival in all defined groups was significantly higher than that in the FBS control group, with even higher survival in the group without RA supplementation.

[0054] 2. Using Micropatterned Surfaces to Promote the Purification and Performance Verification of HiPSC-derived Embryoid-Body Mesenchymal-Like Cells

[0055] 1. Preparation of PDMS micropatterning

[0056] The PDMS precursor polymer and the cross-linking agent were fully mixed at a mass ratio of 10:1, and the thickness was controlled to be 0.2mm. After the mixture was degassed, it was poured into chip positive molds of 5μm, 10μm, 20μm, and 40μm specifications. After the mixture was spread evenly, the mold was placed in a 60°C drying oven overnight. After the polymerization and curing were completed, the PDMS was peeled off from the mold, cut into small discs with a diameter of about 14mm, and placed in a 24-well plate, one disc per well. A mixture of PDMS precursor polymer and cross-linking agent was pre-dropped into the well plate (Pasteur pipette, 1 drop per well). After the disc was placed, it was placed in a drying oven and heated overnight for curing. Then it was soaked in alcohol overnight to obtain 5μm, 10μm, 20μm, and 40μm PDMS micro-patterned surfaces. As Figure 3 As shown, SEM characterization images of PDMS micropatterned surfaces with widths of 0 μm (original), 5 μm, 10 μm, 20 μm, and 40 μm are shown.

[0057] 2. Preparation of PDMS-PNIPAAm-Gelatin Micropatterned Surface

[0058] (1) NIPAAm recrystallization

[0059] Weigh 5 g of NIPAAm into a 250 mL three-necked flask and add 50 mL of n-hexane solution. Heat in a 55°C water bath under reflux. Once the NIPAAm is completely dissolved in the n-hexane, filter while hot and collect the filtrate. Allow the filtrate to stand at room temperature until a large amount of crystals precipitate, then place it in a 4°C refrigerator for 5 hours. Filter under reduced pressure using a sand-core funnel. Dry the collected product in a vacuum oven at room temperature for 12 hours. Remove and weigh the product, seal it, and store it at 4°C.

[0060] (2) NIPAAm monomer solution

[0061] Dissolve 0.1 g of NIPAAm in 1 mL of water. Once fully dissolved, add 10 μL of 50 mM sodium periodate and 0.0005 g of benzyl alcohol (approximately one drop per 1 mL syringe) to create a solution with a NIPAAm concentration of 10% (w / v), a sodium periodate concentration of 0.5 mM, and a benzyl alcohol concentration of 0.5%.

[0062] (3) PDMS micropatterned surface grafting

[0063] A 20% by mass benzophenone acetone solution was added to the well plate at 1 mL per well, and the PDMS micro-patterned surface was treated with a photoinitiator for 5 minutes. The benzophenone acetone solution was quickly aspirated and rinsed with a large amount of ddH2O to ensure that there was no white benzophenone precipitate on the surface. 1 mL of NIPAAm monomer solution was added dropwise to the treated 24-well plate at each well. Then, a 125W high-pressure mercury lamp (excluding the glass shell coated with phosphor) was used for illumination for 30 minutes. The PDMS micro-patterned surface was about 7 cm away from the light source, and the irradiation intensity was 6.75 mW / cm 2 (365 nm). During illumination, the temperature was controlled in an ice-water bath, never exceeding 20°C. Finally, the PNIPAAm-grafted PDMS micropatterned surface was rinsed alternately with ddH2O and acetone to remove residual monomer solution and benzophenone. The surface was then soaked in water for 24 hours and sterilized overnight under UV light. Figure 4 The XPS analysis of the PDMS surface before and after grafting of the PNIPAAm coating is shown; Figure a is a full spectrum of the PDMS surface; Figure b is a full spectrum of the PDMS-PNIPAAm surface; and Figure c is the change in the C1s element content on the PDMS-PNIPAAm surface. The appearance of nitrogen (N1s) at 400.0 eV in the full surface spectrum further confirms the successful grafting of PNIPAAm onto the PDMS surface. Similarly, XPS elemental analysis shows that after coating with PNIPAAm, the surface contains 3.44% N1s. In addition, the high-resolution C1s spectrum can be unrolled into three curves with binding energies centered at 284.0, 285.4, and 288.0 eV, corresponding to C1s in the CH / CC, CN, and C=O states, respectively.

[0064] (4) Gelatin-modified surface preparation

[0065] A 0.1% gelatin solution was prepared using DPBS, dissolved in a 60°C water bath, and filtered using a 0.22 μm filter while hot to obtain a sterile gelatin solution. 250 μL of the solution was added to each well of the PDMS-PNIPAAm well plate and incubated in a 37°C incubator overnight to obtain a PDMS-PNIPAAm-Gelatin micropatterned surface. Figure 5 The surface morphology of PDMS grafted surfaces (PDMS, PDMS-PNIPAAm, PDMS-PNIPAAm-Gelatin) with different widths (0μm, 5μm, 10μm, 20μm, 40μm) scanned by atomic force microscopy is shown.

[0066] Figure 5 Figure 2 shows microgrooved patterns of varying widths (0 μm, 5 μm, 10 μm, 20 μm, and 40 μm) confirmed by scanning electron microscopy and coated with PNIPAAm and gelatin. Furthermore, atomic force microscopy measurements were used to assess changes in surface morphology. Figure 6 Roughness analysis (Ra and Rz parameters) revealed that microgroove modification increased surface roughness. Microgrooves with a width of 10 μm exhibited the highest Ra values ​​compared to the other groups, with no significant differences. Both PNIPAAm coatings, especially gelatin, significantly increased surface roughness, resulting in similar surface roughness values ​​for the final PDMS-PNIPAAm-gelatin substrates.

[0067] 3. Purification of hiPSCs-MSCs

[0068] After 5 days of mesodermal and mesenchymal differentiation, EBs were transferred to 15 mL centrifuge tubes and allowed to settle for approximately 15 minutes. The precipitated EBs were digested into single cells using 0.25% trypsin-EDTA, counted using a cell counter, and seeded at 20,000 cells / mL onto the surfaces of PDMS-PNIPAAm-Gelatin cell culture plates of varying diameters (0 μm, 5 μm, 10 μm, 20 μm, and 40 μm). Mesenchymal differentiation was induced using commercially available, defined mesenchymal (MSC-SFM) medium. After purification, RT-PCR and flow cytometry demonstrated that a 20 μm surface width was the optimal purification width, achieving 98% expression, similar to that of umbilical cord mesenchymal stem cells (UMSCs) in the control group. Figure 7 The results show that hiPSCs-MSCs were seeded onto PDMS-PNIPAAm-Gelatin surfaces of different widths (5μm, 10μm, 20μm, and 40μm) for purification and microscopic observation of cell morphology. Microscopic observation showed that cells adhered well to PDMS-PNIPAAm-Gelatin surfaces of different widths (0μm, 5μm, 10μm, 20μm, and 40μm), growing along the grooves in a long, spindle-like shape. There were slight differences between the groups. Because hUMSCs are approximately 10-20μm in size, the cell morphology in the 5μm grooves showed that the cells were connected in sheets on the groove surface, contacting each other, and not growing completely in the grooves. In the 10μm and 20μm groups, the cell size and grooves were relatively consistent, and the cells grew along the grooves in a long, spindle-like shape. Finally, in the 40μm group, the grooves were wider, and the cells aggregated and grew along the grooves.

[0069] 3. Performance Verification of Purified hiPSC-MSCs

[0070] The hiPSCs-MSCs obtained through the optimal compound induction system and optimal groove width purification were subjected to the following multipotential differentiation identification.

[0071] 1. Chondrogenic differentiation

[0072] HiPSC-MSCs purified using the optimal compound induction system and optimal groove width were cultured to 80% confluence. The culture medium was then replaced with chondrogenic medium (high-glucose DMEM + 1% double-antibody + 0.1 μM dexamethasone + 50 μg / mL ascorbic acid 2-phosphate + 40 μg / mL L-proline + 100 μg / mL sodium pyruvate + 1x insulin-transferrin-selenious acid + 10 ng / mL TGF-β3). Fresh medium was replaced every three days. After 21 days of chondrogenic differentiation, cells were stained with toluidine blue.

[0073] 2. Osteogenic differentiation

[0074] When the confluence of hiPSCs-MSCs reached 80% after purification with the optimal compound induction system and the optimal groove width, the culture medium was replaced with osteogenic medium (α-MEM medium containing 15% fetal bovine serum, 1% non-essential amino acids, 0.1 mM β-mercaptoethanol, 1% double antibody, 5 μg mL -1 Vitamin C, 10 mM sodium glycerophosphate and 10 -8 M dexamethasone), and fresh culture medium was replaced every two days. After 14 days of induction of osteogenic differentiation, alizarin red staining was performed.

[0075] 3. Adipogenic differentiation

[0076] When hiPSC-MSCs reached 80% confluence after purification using the optimal compound induction system and optimal groove width, the culture medium was replaced with adipogenic medium (high-glucose DMEM + 10% FBS + 1% double-antibody + 1 μM dexamethasone, 10 μg / mL insulin, 200 μM indomethacin + 500 μM 3-isobutyl-1-methylxanthine). Fresh medium was replaced every three days. After 21 days of adipogenic differentiation induction, Oil Red O staining was performed.

[0077] exist Figure 8 In a, hiPSCs-MSCs were purified on PDMS-PNIPAAm-Gelatin surfaces of different widths (0μm, 5μm, 10μm, 20μm, 40μm) for 5 days, and adult umbilical cord-derived mesenchymal stem cells (hUMSCs) were detected by RT-PCR and flow cytometry for mesenchymal-like cell markers. It can be seen that the expression levels of all positive marker genes such as CD73, CD44, CD29 and CD45 in the 20μm group cells were significantly higher than those in other groups. In addition, the expression of negative marker genes CD34 and CD14 was downregulated in the 20μm group cells. CD34 is a surface marker for hematopoietic stem cells, while CD14 is a marker for monocytes. More importantly, FCM analysis showed that cells in all groups did not express CD34 ( Figure 8b). This was followed by positive markers CD73 and CD44. Flow cytometry analysis showed that cells in all groups did not express CD34. These results indicate that the obtained hiPSC-mesenchymal stem cells can be effectively purified regardless of the micropatterned surface used. In addition, on the 20μm micropatterned surface, the expression of CD73 and CD44 was closely correlated with that observed in adult stem cells (hUMSCs). The expression of CD73 (93.6%) was comparable to that of hUMSCs (94.4%), while the expression of CD44 in the 20μm microgrooves (94.4%) was slightly lower than that of hUMSCs (99.5%). These findings indicate that a width of 20μm is the optimal width for purifying hiPSC-mesenchymal stem cells. These results indicate that the process of purifying hiPSC-mesenchymal stem cells on a 20μm PDMS micropatterned surface can increase the expression of mesenchymal stem cell-related markers.

[0078] Apart from Figure 8 In order to further verify the differentiation ability of hiPSCs-MSCs obtained by the optimal compound induction system and the optimal groove width purification, the following multipotential differentiation identification was performed. Figure 9 As shown, the osteogenic, chondrogenic, and adipogenic differentiation potential of hiPSC-MSCs purified from PDMS-grafted surfaces was evaluated, using hUMSCs as a control. On day 1, hiPSC-MSCs and hUMSCs exhibited a short spindle-shaped morphology. After up to 7 days of culture, both cells exhibited an elongated spindle shape and were densely arranged in a vortex-like pattern. Furthermore, the proliferation curves measured during the 7-day culture process were nearly identical. Similarly, during all three induction processes of adipogenesis, osteogenesis, and chondrogenesis, both cells developed lipid droplets, red-stained calcium nodules, and blue-stained cartilage, respectively. These findings indicate that there are no significant differences in differentiation potential between hiPSC-MSCs and hUMSCs. In summary, the present invention successfully established an in vitro differentiation induction method to obtain CD73+CD44+ hiPSC-MSCs with trilineage differentiation potential.

[0079] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.

Claims

1. A method for preparing a PDMS-PNIPAAm-Gelatin micro-patterned surface, characterized in that: The method comprises the following steps: (1) treating the PDMS micropatterned surface in the well plate with a photoinitiator and then rapidly removing the photoinitiator; (2) 1 mL of NIPAAm monomer solution was added to each well of the treated plate. The PDMS micropatterned surface was irradiated at a distance of 7 ± 1 cm from the light source at an intensity of 365 nm and 6.75 mW / cm 2 The well plate was exposed to light for 30 minutes under the conditions, during which the temperature of the well plate was controlled not to be higher than 20° C. The well plate after exposure was washed and sterilized to obtain a PDMS micro-patterned surface grafted with PNIPAAm in the well plate; (3) 250 μL of a 0.1% by mass sterile gelatin solution was added to each well of the well plate and incubated in an incubator at 37° C. overnight to obtain a PDMS-PNIPAAm-Gelatin surface in the well plate.

2. The preparation method according to claim 1, characterized in that In step (1), the preparation process of NIPAAm monomer solution is as follows: Add NIPAAm to the n-hexane solution, heat under reflux condensation and 55°C water bath, and when NIPAAm is completely dissolved in n-hexane, filter while hot and collect the filtrate; The filtrate was placed at room temperature until a large amount of crystals were precipitated, and then placed in a 4°C refrigerator for 5 hours, and filtered under reduced pressure using a sand core funnel. The collected product was dried under vacuum at room temperature for 12 hours to obtain recrystallized NIPAAm; The recrystallized NIPAAm was fully dissolved in water, and 50 mM sodium periodate and benzyl alcohol were added to prepare a NIPAAm monomer solution with a NIPAAm concentration of 10% (w / v), a sodium periodate concentration of 0.5 mM, and a benzyl alcohol concentration of 0.5%.

3. The method according to claim 1, characterized in that In step (2), the preparation process of the PDMS micro-patterned surface in the well plate is specifically as follows: The PDMS precursor and the cross-linking agent were fully mixed at a mass ratio of 10:1, and the thickness was controlled to be 0.2 mm. After the mixture was degassed, it was poured into a chip positive mold with a specification of 5-40 μm. After the mixture was evenly spread, the mold was placed in a drying oven at 60±1℃ overnight; After polymerization and curing, the PDMS was peeled off from the mold and cut into discs with a diameter of 14 ± 0.1 mm; A mixture of PDMS precursor and cross-linking agent was pre-dropped in the well plate, and a disc was placed in each well of the well plate. The disc was cured at 60°C overnight and soaked in alcohol overnight to obtain a PDMS micro-patterned surface with a thickness of 5 to 40 μm.

4. The method according to claim 3, characterized in that After degassing, the mixture was poured into a 20 μm chip positive mold, and finally a PDMS micro-patterned surface with a thickness of 20 μm was obtained.

5. The method according to claim 1, characterized in that In step (2), the PDMS micro-patterned surface in the well plate is treated with a photoinitiator by using a 20% by mass benzophenone acetone solution as a photoinitiator, and adding 1 mL of the photoinitiator to each well of the well plate for 5 minutes.

6. The method according to claim 1, characterized in that In step (2), the specific process of rapidly removing the benzophenone-acetone solution is: rapidly absorbing the benzophenone-acetone solution and washing it with a large amount of ddH2O to ensure that there is no white benzophenone precipitate on the surface.

7. The method according to claim 1, characterized in that In step (2), in step (2), the temperature of the orifice plate is controlled to be no higher than 20° C. by an ice water bath.

8. The method according to claim 1, characterized in that In step (2), the specific process of washing and sterilization is as follows: the PDMS micropatterned surface grafted with PNIPAAm in the well plate is rinsed alternately with ddH2O and acetone to remove residual monomer solution and benzophenone, and then immersed in water for 24 hours and sterilized under ultraviolet light overnight.

9. The PDMS-PNIPAAm-Gelatin surface prepared by the method according to any one of claims 1 to 8.

10. Use of the PDMS-PNIPAAm-Gelatin surface according to claim 9 in inducing mesenchymal differentiation of mesenchymal-like cells hiPSCs-MSCs derived from human induced pluripotent stem cells.

Citation Information

Patent Citations

  • Preparation method and application of temperature-sensitive patterned polymer surface with orientation structure

    CN102643448A

  • Micro-patterned temperature-sensitive chitosan membrane and preparation method thereof

    CN102942705A

  • Surface patterning high-strength and high-toughness hybrid hydrogel membrane and preparation method thereof

    CN103205006A

  • Three dimensional cell patterned bioploymer scaffolds and method of making the same

    US20050169962A1

  • Stacked, patterned biomaterials and / or tissue engineering scaffolds

    US20100167401A1